CIK 0001728328
- Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 604-669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Material agreement · Shareholder rights changed
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K/A Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 8-K/A Event Regulation FD disclosure
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Other events
Page 8 of 11 · 203 filings